Breast Implant Patient Preferences Topic Of New FDA Study
Executive Summary
The US agency’s study will look at how the potential cancer risk tied to textured breast implants, as well as other factors, play into how patients decide what type of implants to get.
You may also be interested in...
New Cancer Risks Linked To Breast Implants, FDA Warns
The US FDA has learned of new cancer risks associated with breast implants that differ from cancers the agency has warned about in the past.
FDA: 36 Dead From Breast Implant-Associated Lymphoma Since 2019, Hundreds Sickened
The US FDA reports the numbers on women globally who've died or been sickened by two types of breast implant illnesses.
OIG: FDA’s EUA Approach Allowed Bad Tests To Reach Market
A review by a government watchdog found the FDA’s review process for COVID-19 diagnostics was plagued by issues including allowing low-quality tests to slip through, high reviewer workloads, and manufacturer frustration.